Clinical Trials Logo
  1. Home
  2. Aortic Regurgitation
  3. NCT02732704

THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

Aortic Regurgitation Clinical Trial

Official title:
THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Clinical Trial Summary

To collect information about treatment for severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allows some blood to leak back into the heart chamber. Symptoms of aortic regurgitation may include fatigue and shortness of breath. The preferred treatment for severe aortic regurgitation is aortic valve replacement surgery.

Clinical Trial Description

This study will examine the use of TAVR (Transcatheter Aortic Valve Replacement), which is a minimally invasive procedure designed to replace the aortic valve inside the heart. In this study, TAVR will be performed using the JenaValve Pericardial TAVR System, which is intended to help treat severe aortic regurgitation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02732704
Study type Interventional
Source JenaValve Technology, Inc.
Contact
Status Active, not recruiting
Phase N/A
Start date April 20, 2018
Completion date September 29, 2027
View Details
See also
  Status Clinical Trial Phase
Completed NCT03314857 - China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population N/A
Completed NCT03666351 - Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease Phase 4
Recruiting NCT06034028 - J-Valve TF Early Feasibility Study N/A
Completed NCT05515848 - Aortic Valve-sparing Root Replacement, According to the Inclusion Technique Described by Tirone David
Active, not recruiting NCT03549091 - Accuracy of Left Subclavian Regurgitation Evaluated by Ultrasound Doppler and 4D Flow MRI N/A
Completed NCT01598844 - JUPITER Study: Transapical Aortic Valve Implantation for Aortic Regurgitation
Active, not recruiting NCT03466918 - China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population N/A
Active, not recruiting NCT04415047 - The JenaValve ALIGN-AR Pivotal Trial N/A
Not yet recruiting NCT05319171 - Performance of Currently Available traNscaTHEter Aortic Valve Platforms in Inoperable Patients With Pure Aortic regurgitatiON of a Native Valve. The PANTHEON International Project.
Completed NCT05774795 - LOng-Term Fate of Moderate Aortic Regurgitation Left Untreated at the Time of Mitral Valve Surgery
Terminated NCT02351726 - Mitroflow DL Post Approval Study- North America N/A
Completed NCT00624884 - Velocity Vector Imaging in Patients With Moderate-to-Severe Aortic Regurgitation N/A
Withdrawn NCT05409378 - HLT® Meridian® TAVR Valve System Early Feasibility Study for Aortic Regurgitation N/A
Recruiting NCT04038879 - Comparison Study of Echocardiography and Cardiovascular Magnetic Resonance Imaging in the Assessment of Mitral and Aortic Regurgitation
Completed NCT05332184 - Cardiac T1 Mapping Enables Risk Prediction of LV Dysfunction After Surgery for Aortic Regurgitation
Completed NCT01400841 - HAART Model 300 Annuloplasty Ring N/A
Not yet recruiting NCT02633423 - Expiratory Flow Limitation and Mechanical Ventilation During Cardiopulmonary Bypass in Cardiac Surgery N/A
Completed NCT00976625 - Diastolic Dysfunction in Aortic Regurgitation N/A
Enrolling by invitation NCT05714293 - CT-evaluation of Coronary Ostia Height After Surgical Aortic Valve Replacement. N/A
Recruiting NCT02974920 - Rivaroxaban or Aspirin for Biological Aortic Prosthesis Phase 4